Literature DB >> 32323862

What can Parkinson's disease teach us about COVID-19?

Philip W Tipton1, Zbigniew K Wszolek2.   

Abstract

Entities:  

Keywords:  COVID-19; Parkinson’s disease; amantadine; memantine

Mesh：

Substances：

Year:  2020        PMID： 32323862     DOI： 10.5603/PJNNS.a2020.0039

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN： 0028-3843            Impact factor:   1.621


× No keyword cloud information.
  12 in total

Review 1.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

2.  Potential impact and challenges associated with Parkinson's disease patient care amidst the COVID-19 global pandemic.

Authors:  Ali Elbeddini; Anthony To; Yasamin Tayefehchamani; Cindy Wen
Journal:  J Clin Mov Disord       Date:  2020-08-08

3.  Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.

Authors:  Konrad Rejdak; Paweł Grieb
Journal:  Mult Scler Relat Disord       Date:  2020-04-30       Impact factor: 4.339

Review 4.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

5.  Influence of the COVID-19 Pandemic on Quality of Life of Patients with Parkinson's Disease.

Authors:  Dengjun Guo; Bing Han; Yuqiang Lu; Chenling Lv; Xiaoling Fang; Zhenzhong Zhang; Zhenguo Liu; Xiaoping Wang
Journal:  Parkinsons Dis       Date:  2020-10-05

6.  Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2.

Authors:  Albert Cortés-Borra; Gonzalo Emiliano Aranda-Abreu
Journal:  Pharmacol Rep       Date:  2021-02-18       Impact factor: 3.024

7.  Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19?

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  J Pers Med       Date:  2020-11-09

Review 8.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575

Review 9.  Bias Investigation in Artificial Intelligence Systems for Early Detection of Parkinson's Disease: A Narrative Review.

Authors:  Sudip Paul; Maheshrao Maindarkar; Sanjay Saxena; Luca Saba; Monika Turk; Manudeep Kalra; Padukode R Krishnan; Jasjit S Suri
Journal:  Diagnostics (Basel)       Date:  2022-01-11

10.  Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients.

Authors:  Diego Santos-García; Mila Oreiro; Patricia Pérez; Gemma Fanjul; Jose Manuel Paz González; María José Feal Painceiras; Carlos Cores Bartolomé; Lorena Valdés Aymerich; Carlos García Sancho; Maria Del Mar Castellanos Rodrigo
Journal:  Mov Disord       Date:  2020-09-22       Impact factor: 9.698
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.